Drugs / Panthenol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01533220 | Jan → Aug 2013 | allergic respiratory disease, influenza | EMS | Completed | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 3 | NCT02379468 Comparator | Apr 2013 → Aug 2014 | ulcer of lower limbs | European Egyptian Pharmaceutical Industries | Completed | No outcome recorded |
| Phase 3 | NCT01531517 Comparator | Jul 2011 → Jul 2012 | ulcer of lower limbs | European Egyptian Pharmaceutical Industries | Terminated | No outcome recorded Stop: Enrollment |
| — | NCT04835259 Comparator | Apr 2021 → Apr 2022 | — | Sohag University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Panthenol | “panthenol 2% cream, El Nile company, Egypt” NCT04835259 ↗ |
| Known as | Panthenol cream | “topical panthenol (Panthenol cream)” NCT04835259 ↗ |
| Route | Topical | “local application of either PEDYPHAR or Panthenol ointment under dressing” PMID 31564933 ↗ Sep 2019 |